Abstract
Nitric Oxide (NO) has been proposed as a new neurotransmitter/neuromodulator in the Central Nervous System (CNS). Microinjections of inhibitors of NO synthase (NOS) the enzyme responsible for NO formation into the dorsal central grey induce anxiolytic effects in rats. On the other hand SIN-1 a NO donor microinjected into these regions induces flight reactions. However although systemic injections of low doses of NOS inhibitors induce anxiolytic effects in the elevated plus maze higher doses decrease maze exploration. This may involve motor effects of this compounds since we showed that they can induce catalepsy in a dose dependent manner in rodents either after systemic or Intra-striatal injections. These results suggest that NO may be related to the control of motor and emotional behaviour.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abekawa, T; Ohmori, T., Koyama, T.: Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine. Brain Res. 666 147–150 (1994)
Babbedge R.C. Hart S.L. Moore P.K.: Antinociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J. Pharmacol.45 77–79 (1993a)
Babbedge R.C. et al.: L-NG-nitro-arginine p-nitroanilide (L-NAPNA) is antinociceptive in the mouse. Neuroreport4 307–310 (1993b).
Barjavel M.J Bhargava H.N.: Nitric oxide synthase activity in regions and spinal cord of mice and rats: kinetic analysis. Pharmacology 50 168–174 (1995)
Bohme C.A. et al.: Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol. 199 379–381 (1991)
Bowyer J.F. et al.: Nitric Oxide regulation of metjanphetamine-induced dopamine release in caudate /putamen. Brain Res. 699 62–70 (1995)
Bredt D.S. Hwang P.M. Snyder S.H.: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347 768–770 (1990)
Bredt D.S. Snyder S.H.: Isolation of nitric oxide synthetase a calmodulinÂrequiring enzyme. Biochemistry 87 682–685 (1990)
Caton P.W. Tousman S.A. Quock R.M.: Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze. Pharmacol. Biochem. Behay. 48 689–692 (1994)
Choi D.W.: Nitric oxide: foe or friend to the injured brain. Proc. Natl. Acad. Sci. USA 90 9741–9743 (1993)
Coderre T.J.: The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol. Neurobiol. 7 229–246 (1994)
Dawson T.M. et al.: Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissue. Proc. Natl. Acad. Sci. 88 7797Â-7801 (1991)
Del Bel, E.A., da Silva, C.A., GuimarĂ£es, F.S.: Catalepsy induced by nitric Oxide Syntase inhibitors. General Pharmacology in press.
Del Bel, E.A. et al.: Anticonvulsant and proconvulsant robos of Nitric Oxide in experimental epilepsy models Brazilian J. Med. Biol. Res. in press.
Faria, M.S. et al.: Acute inhibition of nitric oxide synthesid induces anxiolysis in the plus maze test Europ. J. Pharmacol. 323 37–43 (1997)
Forstermann U. et al.: Characterization and purification from different cell types. In: Commentary Isoforms of Nitric Oxide Synthase. Biochem. Pharmacol. 42 1849–1857 (1991)
Garthwaite J.: Glutamate nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14 60–67 (1991)
Graeff, F.G. et al.: Role of 5HT in stress anxiety and depression. Pharmacol. Biochem. Behay. 54 129–141 (1996)
Graeff F.G.: Brain defence system and anxiety. In: Roth M. Burrows G.D. Noyes R. (eds) Handbook of anxiety Vol. 3. Amsterdam: Elsevier 1990 pp. 307–354
GuimarĂ£es F.S. et al.: Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 103 91–94 (1991)
GuimarĂ£es F.S. et al.: Anxiolytic effect of nitric oxide inhibitors microinjected into the dorsal central grey. NeuroReport 5 1929–1932 (1994)
Hirsh E. et al.: Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and progressive supranuclear palsy. Proc. Natl. Acad. Sci. USA 84 5976–5980 (1987)
Hope B.T. et al.: Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. USA 88 2811–2814 (1991)
Kolesnikov Y.A. Pick C.G. Pasternak G.W.: NG-Nitro-L-Arginine prevents morphine tolerance. Eur. J. Pharmacol. 221 399–400 (1992)
Linden D.J. Connor J.A.: Long-term depression of glutamate currents in cultured cerebellar Purkinje neurons does not require nitric oxide signalling. Eur. J. Neurosci. 4 10–15 (1991)
Lino de Oliveira C. Del Bel E.A. GuimarĂ£es F.S.: Effects of L-NOARG on plus-maze performance in rats. Pharmacol. Biochem. Behay. 56 55–59 (1997)
Lipton S.A. et al.: A redox-based mechanism for the neuroprotective effects of nitric oxide and related nitroso-compounds. Nature 364 626–632 (1993)
Marras, R. et al.: L-NOARG an inhibitor of nitric oxide synthase induces catalepsy in mice. NeuroReport 7 158–160 (1995)
Matheus, M.G., GuimarĂ£es, F.S.: Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze. Psychopharmacology in press.
Mollace V. Bagetta G. Nistico G.: Evidence that L-arginine possesses proconvulsant effects mediated through nitric oxide. Neuroreport 2 269–272 (1991)
Moncada S. Higgs A.: The 1-arginine pathway. N. Engl. J. Med. 329 2002Â2012 (1993)
Moncada S. Palmer R.M.J. Higgs E.A.: Nitric oxide: physiology pathophysiology and pharmacology. Pharmacol. Rev. 43 109–142 (1991)
Moore N.A. et al.: NMDA receptor antagonism inhibit catalepsy induced by either dopamine Dl or D2 receptor antagonist. Eur. J. Pharmacol. 237 1–7 (1993)
O’Dell T.J. et al.: Test of the roles of two difusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl. Acad. Sci. USA 88 11285–11289 (1991)
Ogle C.W. QiuB.S.: Nitric oxide inhibition intensifies cold-restraint induced gastric ulcers in rats. Experentia 49 304–307 (1993)
Oliveira G.M. Rosa W.C.M. Nakamura-Palacios E.M.: Effect of age and magnesium administration on the performance of SHR in the elevated plus-maze. Brazilian J. Med. Biol. Res. 28 343–346 (1995)
Onstott D. Mayer B. Beitz A.J.: Nitric oxide synthase immunoreactive neurons anatomically define a longitudinal dorsolateral column within the midbrain periaqueductal grey of rat: analysis using laser confocal microscopy. Brain Res. 610 317–324 (1993)
Papa M. Pellicano M.P. Sadile A.G.: Nitric oxide and long-term habituation to novelty in the rat. Ann. N. Y. Acad. Sci. 738 316–324 (1993)
Paxinos G. Watson C.: The rat brain in stereotaxic coordinates. second edition San Diego: Acdemic Press 1986
Quock R.M. Nguyen E.: Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice. Life Sci. 51 255–260 (1996)
Ribeiro M.O. et al.: Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20 298–303 (1994)
Rosa W.C.M. Oliveira G.M. Nakamura-Palacios E.M.: Effects of antihypertensive drugs alfa-methyldopa and hydralazine on plus maze. Braz.J. Med. Biol. Res. 27, 55 (1994)
Salter M. Duffy C. Hazelwood R.: Determination of brain nitric oxide synthase inhibition in vivo: Ex vivo assays of nitric oxide synthase can give incorrect results. Neuropharmacology 34 327–334 (1995)
Sanberg P.R. et al.: The catalepsy test: its ups and downs. Behay. Neurosci. 102 748–759 (1988)
Sandi C. Venero C. GuazaC.: Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treatted rats Eur. J. Pharmacol. 277 89–97 (1995)
Sandor, N.T. et al.:Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res. Bull. 36 483–486 (1995)
Shibuki K. Okada D.: Endogenous nitric oxide release required for long term synaptic depression in the cerebellum. Nature 349 326–328 (1991)
Silva M.T. et al.: Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole. Brit. J. Pharmacol. 114 257–258 (1994)
Silveira, M.C.L. et al.:C-fos immunoreactivity in the brain following electrical or chemical stimulation of the medial hypothalamus of freely moving rats. Brain Res. 674 265–274 (1995)
Snyder S.H. Bredt D.S.: Nitric oxide as a neuronal messenger. Trends Pharmac. Sci. 12 125–128 (1991)
Spinella M. Bodnar R.J.: Nitric oxide synthase inhibition selectively potentiates swim stress antinociception in rats. Pharmacol. Biochem. Behay. 47 727–733 (1994)
Star M.S. Star B.S.: Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Europ. J. Pharmacol. 272 211–217 (1994)
Sugaya K. McKiney M.: Nitric Oxide Synthase expression in cholinergic neurons in the rat brain examined by combined immunocythochemistry and in situ hybridization histhochemistry. Mol. Brain Res. 23 111–125 (1994)
Vicent S.R. Kimura H.: Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46 755–784 (1992)
Volke V. et al.: Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. NeuroReport 6 1285–1288 (1995)
Yoshida Y. et al.: Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudadte-putamen. Brain Res. 639 139–148 (1994)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Del Bel, E.A., de Oliveira, R.M.W., GuimarĂ£es, F.S. (1998). Role of Nitric Oxide on Emotional and Motor Behaviour. In: Torre, V., Nicholls, J. (eds) Neural Circuits and Networks. NATO ASI Series, vol 167. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58955-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-58955-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63801-5
Online ISBN: 978-3-642-58955-3
eBook Packages: Springer Book Archive